DocSym
β
Searchsearch
Search
(L40.0) Psoriasis vulgaris
More details coming soon
3 464 693 in individuals diagnosis psoriasis vulgaris confirmed
4 004 deaths with diagnosis psoriasis vulgaris
Diagnosis psoriasis vulgaris is diagnosed Men are 18.43% more likely than Women
2 051 620
Men receive the diagnosis psoriasis vulgaris
1 401 (less than 0.1%)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
1 413 073
Women receive the diagnosis psoriasis vulgaris
2 603 (0.2 %)Died from this diagnosis.
Risk Group for the Disease psoriasis vulgaris - Men and Women aged 55-59
In Men diagnosis is most often set at age 0-95+
in in men, the disease manifests at any agein in women, the disease manifests at any age
In Women diagnosis is most often set at age 0-95+
Disease Features psoriasis vulgaris
Absence or low individual and public risk
Psoriasis vulgaris - what does this mean
Psoriasis vulgaris is a chronic, inflammatory skin disorder caused by an overactive immune system. it is characterized by red, scaly patches of skin, known as plaques, which can be itchy and painful. the plaques are caused by an overproduction of skin cells, which build up on the skin's surface.
What happens during the disease - psoriasis vulgaris
Psoriasis vulgaris is an autoimmune condition characterized by the overproduction of skin cells. it is caused by a combination of genetic and environmental factors, such as stress, infections, and certain medications. this leads to an overactive immune response, causing the skin cells to multiply more quickly than normal. as a result, the skin becomes thick and scaly, and plaques form on the surface of the skin. these plaques are often itchy and can be painful.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination of the skin
- Medical history and family history
- Laboratory tests such as blood tests and skin biopsy
- X-rays of the affected area
- Imaging tests such as ultrasound or MRI
- Allergy tests
- Genetic testing
Treatment and Medical Assistance
Main goal of the treatment: To reduce the symptoms of psoriasis vulgaris and improve the quality of life of the patient.
- Topical treatments such as corticosteroids, vitamin D analogs, retinoids, calcineurin inhibitors, coal tar, anthralin, and salicylic acid.
- Phototherapy, such as narrowband ultraviolet B (UVB) therapy.
- Systemic medications, such as methotrexate, cyclosporine, and biologic agents.
- Lifestyle modifications such as stress reduction, avoiding triggers, and moisturizing the skin.
- Dietary changes such as reducing the intake of processed foods, saturated fats, and refined carbohydrates.
20 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Psoriasis vulgaris - Prevention
Psoriasis vulgaris can be prevented by avoiding triggers such as stress, smoking, alcohol, and certain medications. additionally, maintaining a healthy lifestyle with a balanced diet, regular exercise, and adequate sleep can help reduce the risk of developing psoriasis.